Abiraterone

General Information

Abiraterone Impurities and Abiraterone  

Daicel Pharma synthesizes high-quality Abiraterone impurities like Abiraterone Acetate Impurity, Abiraterone Dimer Impurity, Abiraterone Ethyl Ether, Abiraterone Methyl Ether, Abiraterone propionate Impurity, Abiraterone Sulfate, and more, which are crucial in the analysis of the quality, stability, and biological safety of the active pharmaceutical ingredient Abiraterone. Moreover, Daicel Pharma offers custom synthesis of Abiraterone impurities and delivers them globally.

Abiraterone [CAS: 154229-19-3] is a steroidal compound having antiandrogenic properties. Abiraterone is a medicine that treats metastatic prostate cancer in men who have undergone castration. It inhibits the activity of steroid 17 alpha-monooxygenase, also known as CYP17A1. This enzyme is a member of the cytochrome p450 family and helps in testosterone synthesis.

Abiraterone: Use and Commercial Availability  

Abiraterone, available under the trade name Zytiga, was the first drug to work through its mechanism. It is an irreversible inhibitor of the enzyme CYP17A1, crucial for androgens and estrogens preparation in both the adrenal glands and tumor tissues. Therefore, Abiraterone suppresses androgen synthesis in both of these locations. Abiraterone is available as abiraterone acetate combines with either methylprednisolone or prednisone and treats metastatic castration-resistant prostate cancer (CRPC) or metastatic high-risk castration-sensitive prostate cancer (CSPC). The other trade name of Abiraterone is Yonsa.

Abiraterone Structure and Mechanism of Action

The chemical name of Abiraterone is (3β)-17-(3-Pyridinyl)androsta-5,16-dien-3-ol. Its chemical formula is C₂₄H₃₁NO, and its molecular weight is approximately 349.5 g/mol.

Abiraterone inhibits 17 α-hydroxylase/C17,20-lyase (CYP17) enzyme expressed in testicular, adrenal, and prostatic tumor tissues. It is for androgen biosynthesis.

Abiraterone Impurities and Synthesis

The most common Abiraterone impurities are related to the starting materials used in the synthetic process¹. Impurities can form during the reaction process or as a result of the degradation of the drug substance. Controlling these impurities is vital for maintaining drug quality, safety, and efficacy.

Daicel provides a Certificate of Analysis (CoA) for Abiraterone impurity standards, including Abiraterone Acetate Impurity, Abiraterone Dimer Impurity, Abiraterone Ethyl Ether, Abiraterone Methyl Ether, Abiraterone propionate Impurity, Abiraterone Sulfate, and more. The CoA is issued from a cGMP-compliant analytical facility and contains complete characterization data, such as 1H NMR, 13C NMR, IR, MASS, and HPLC purity^2,3. Additional characterization data, such as 13C-DEPT and CHN, can be provided upon request. Daicel can also prepare any unknown Abiraterone impurity or degradation product and offer labeled compounds to quantify the efficacy of Abiraterone. Daicel offers Abiraterone acetate-D3, a deuterium-labeled Abiraterone compound used in bio-analytical research such as BA/BE studies. We give a complete characterization report on delivery.